Awakn Life Sciences Corp.
AWKNF
$0.065
-$0.0147-18.44%
OTC PK
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.63M | -1.83M | -2.95M | -3.72M | -4.76M |
| Total Depreciation and Amortization | 13.70K | 15.00K | 14.30K | 13.40K | 12.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 168.90K | 222.90K | -2.02M | -1.52M | -1.52M |
| Change in Net Operating Assets | 573.60K | 672.70K | 795.50K | 877.30K | 319.90K |
| Cash from Operations | -876.20K | -922.80K | -4.16M | -4.35M | -5.94M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -45.00K | -45.00K | 500.00 | 500.00 | 45.50K |
| Other Investing Activities | 45.00K | 45.00K | 36.80K | -15.10K | -59.40K |
| Cash from Investing | 0.00 | 0.00 | 37.40K | -14.50K | -13.80K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.18M | 1.55M | 1.80M | 2.69M | 4.48M |
| Repurchase of Common Stock | -78.70K | -78.70K | -78.70K | -78.70K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 45.70K | 45.70K | -42.40K | -154.30K | -313.90K |
| Cash from Financing | 838.70K | 1.11M | 1.25M | 1.82M | 3.09M |
| Foreign Exchange rate Adjustments | -1.90K | 12.30K | 233.80K | -6.80K | -8.30K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -39.50K | 204.00K | -2.64M | -2.55M | -2.87M |